David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Cambridge Quarterly of Healthcare Ethics 13 (04):417-419 (2004)
In November 2003, researchers at Cambridge University announced they had identified a gene associated with an elevated risk of breast and related ovarian cancers. The gene—christened EMSY in honor of a breast-cancer nurse who is the sister of the study's lead author—is particularly significant because it is linked to so-called sporadic cancers. Such cancers do not arise from hereditary mutations of the BRCA1 and BRCA2 genes, in which genes that ordinarily prevent breast and ovarian cancers are altered, often giving rise to multiple cases of cancer within a family as the mutation is passed along. The Cambridge researchers determined that the presence of extra copies of EMSY in an individual may instead switch off a healthy BRCA2 gene
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Frances M. Alexakos, Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer.
Frances M. Alexakos (2003). Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer. Dissertation, Salve Regina University
Ellen Matloff & Arthur Caplan (2008). Direct to Confusion: Lessons Learned From Marketing Brca Testing. American Journal of Bioethics 8 (6):5 – 8.
David J. Doukas & Jessica W. Berg (2001). The Family Covenant and Genetic Testing. American Journal of Bioethics 1 (3):2 – 10.
Megan Eide & Ann Milliken Pederson (2009). God, Disease, and Spiritual Dilemmas: Reading the Lives of Women with Breast Cancer. Zygon 44 (1):85-96.
Lisa Bortolotti & Heather Widdows (2011). The Right Not to Know: The Case of Psychiatric Disorders. Journal of Medical Ethics 37 (11):673-676.
Roy Gilbar & Ora Gilbar (2009). The Medical Decision-Making Process and the Family: The Case of Breast Cancer Patients and Their Husbands. Bioethics 23 (3):183-192.
Nancy Green (2012). Argumentation and Risk Communication About Genetic Testing: Challenges for Healthcare Consumers and Implications for Computer Systems. Journal of Argumentation in Context 1 (1):113-129.
N. Press, J. R. Fishman & B. A. Koenig (2000). Collective Fear, Individualized Risk: The Social and Cultural Context of Genetic Testing for Breast Cancer. Nursing Ethics 7 (3):237-249.
Rebecca Dresser (2011). Bioethics and Cancer: When the Professional Becomes Personal. Hastings Center Report 41 (6):14-18.
Elisabeth Hildt (2002). Autonomy and Freedom of Choice in Prenatal Genetic Diagnosis. Medicine, Health Care and Philosophy 5 (1):65-72.
Myriam Skrutkowska & Charles Weijer, Do Patients with Breast Cancer Participating in Clinical Trials Receive Better Nursing Care?
Nancy Berlinger (2005). After Harm: Medical Error and the Ethics of Forgiveness. Johns Hopkins University Press.
Alison Reiheld (2010). Patient Complains of … How Medicalization Mediates Power and Justice. International Journal of Feminist Approaches to Bioethics 3 (1):72-98.
Sorry, there are not enough data points to plot this chart.
Added to index2010-08-24
Total downloads1 ( #467,071 of 1,140,105 )
Recent downloads (6 months)0
How can I increase my downloads?